$1.05
0.010.96%
At Close: -
$1.09
0.043.81%
After Hours: 5:41 PM EDT
15 minutes delayed
Protalix BioTherapeutics
PLXAMEX
Protalix BioTherapeutics (PLX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestProtalix BioTherapeutics (AMEX:PLX) Stock Quotes, Forecast and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open | $1.07 |
| Close | $1.05 |
| Volume / Avg. | 446.92K / 557.16K |
| Day Range | 1.04 - 1.10 |
| 52 Wk Range | 1.02 - 2.09 |
| Market Cap | $79.91M |
| P/E Ratio | 13.00 |
| Dividend Yield | - |
| Exchange | AMEX |
| RSI | 43 |
| Short Interest | 8.45% |
| Days to Cover | 24.8 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Protalix BioTherapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercia...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX:PLX) through any online brokerage.
Who are Protalix BioTherapeutics (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), T2 Biosystems (NASDAQ:TTOO) and Eagle Pharmaceuticals (NASDAQ:EGRX).
What is the target price for Protalix BioTherapeutics (PLX) stock?
There is no analysis for Protalix BioTherapeutics.
What is the forecast for Protalix BioTherapeutics (PLX) stock?
Protalix BioTherapeutics has a consensus price target of $10.00.
Current stock price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.09 last updated July 5, 2024 at 5:41 PM EDT.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There are no upcoming dividends for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.